Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statement of Cash Flows

v3.5.0.2
Consolidated Statement of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Statement of Cash Flows [Abstract]    
Net income (loss) $ 52,944 $ (33,787)
Adjustments to reconcile net income (loss) to cash provided by operating activities:    
Amortization and depreciation 18,743 31,162
Impairment of IPR&D assets 1,300 0
Provision for losses on accounts receivable 87 0
Provision for inventory reserves 9 0
Amortization of investment premiums, net 95 261
Amortization of inventory step-up 2,989 14,244
Stock-based compensation 16,475 15,052
Deferred income taxes 215 (1,709)
(Gain) loss on disposal of property and equipment 48 (39)
(Gain) loss on sale of available-for-sale securities (50) 21
Change in fair value of contingent consideration 209 (123)
Impairment of long-lived assets 0 153
Impairment of lease 0 6,161
Loss on foreign currency 66 0
Excess tax benefits on stock based awards (6,042) 0
Changes in operating assets and liabilities:    
Accounts receivable (7,360) 5,971
Inventory 6,955 (10,069)
Prepaid expenses and other assets (365) 700
Accounts payable, accrued expenses and other current liabilities 2,497 (8,822)
Accrued compensation 3,357 4,845
Deferred revenue and deferred profit 1,228 526
Accrued price protection liability (2,914) 6,200
Other long-term liabilities (772) (264)
Net cash provided by operating activities 89,714 30,483
Investing Activities    
Purchases of property and equipment (6,828) (1,480)
Purchases of intangible assets (390) (100)
Cash used in acquisition, net of cash acquired (101,000) (3,615)
Purchases of available-for-sale securities (80,263) (45,680)
Maturities of available-for-sale securities 88,711 57,508
Net cash provided by (used in) investing activities (99,770) 6,633
Financing Activities    
Repurchases of common stock (3) (101)
Net proceeds from issuance of common stock 4,450 6,346
Minimum tax withholding paid on behalf of employees for restricted stock units (6,184) (4,528)
Equity issuance costs 0 (705)
Net cash provided by (used in) financing activities (1,737) 1,012
Effect of exchange rate changes on cash and cash equivalents (87) (675)
Increase (decrease) in cash and cash equivalents (11,880) 37,453
Cash and cash equivalents at beginning of period 67,956 20,696
Cash and cash equivalents at end of period 56,076 58,149
Supplemental disclosures of cash flow information:    
Cash paid for income taxes 1,483 0
Issuance of restricted stock units to Physpeed continuing employees 578 0
Issuance of accrued share-based bonus plan $ 7,649 $ 5,459